Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367120
Status:
COMPLETED
Last Update Posted:
2010-03-16
First Post:
2006-08-21
Brief Title:
Zmax Compared to Augmentin in Sinusitis
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Multicenter Randomized Open Label Comparative Study Of Azithromycin Extended Release ZMAX Versus AmoxicillinClavulanate Potassium In Subjects With Acute Bacterial Sinusitis ABS In A Physician Practice Environment
Status:
COMPLETED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will enroll patients with Bacterial Sinusitis who will be treated with either Zmax Azithromycin Extended Release or Augmentin AmoxicillinClavulanate The purpose of the study is to compare early resolution of symptoms between the two treatments Patients will report resolution of their sinusitis symptoms through a daily questionnaire There will be two follow-up telephone interviews on days 12 and 28 to evaluate quality of life satisfaction with therapy and use of healthcare services
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None